Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Multiple sclerosis"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica
Sonia Patricia Castedo Paz, Luciana Branco, Marina Alves de Camargo Pereira, Caroline Spessotto, Yara Dadalti Fragoso
Epidemiol Health. 2018;40:e2018001.   Published online January 5, 2018
DOI: https://doi.org/10.4178/epih.e2018001
  • 14,791 View
  • 513 Download
  • 18 Citations
AbstractAbstract PDF
Abstract
OBJECTIVES
John Cunningham virus (JCV) is a polyoma virus that infects humans, mainly in childhood or adolescence, and presents no symptomatic manifestations. JCV can cause progressive multifocal leukoencephalopathy (PML) in immunosuppressed individuals, including those undergoing treatment for multiple sclerosis (MS) and neuromyelitis optica (NMO). PML is a severe and potentially fatal disease of the brain. The prevalence of JCV antibodies in human serum has been reported to be between 50.0 and 90.0%. The aim of the present study was to review worldwide data on populations of patients with MS and NMO in order to establish the rates of JCV seropositivity in these individuals.
METHODS
The present review followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and used the following search terms: “JCV” OR “JC virus” AND “multiple sclerosis” OR “MS” OR “NMO” OR “neuromyelitis optica” AND “prevalence.” These terms were searched for both in smaller and in larger clusters of words. The databases searched included PubMed, MEDLINE, SciELO, LILACS, Google Scholar, and Embase.
RESULTS
After the initial selection, 18 papers were included in the review. These articles reported the prevalence of JCV antibodies in the serum of patients with MS or NMO living in 26 countries. The systematic review identified data on 29,319 patients with MS/NMO and found that 57.1% of them (16,730 individuals) were seropositive for the anti-JCV antibody (range, 40.0 to 69.0%).
CONCLUSIONS
The median worldwide prevalence of JCV among adults with MS or NMO was found to be 57.1%.
Summary
Korean summary
Key Message

Citations

Citations to this article as recorded by  
  • Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies
    Panagiotis T. Diamantopoulos, Konstantinos Kalopisis, Aikaterini Tsatsou, Athina Efthymiou, Nefeli Giannakopoulou, Sevastianos Hatzidavid, Nora‐Athina Viniou
    European Journal of Haematology.2022; 108(5): 359.     CrossRef
  • B cells going viral in theCNS: Dynamics, complexities, and functions of B cells responding to viral encephalitis
    Amber Cardani‐Boulton, Brendan T. Boylan, Volodymyr Stetsenko, Cornelia C. Bergmann
    Immunological Reviews.2022; 311(1): 75.     CrossRef
  • Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosis
    M. Gaughan, M. Gilligan, I. Patterson, I. McGurgan, S.M. Yap, N. Tubridy, C. McGuigan
    Multiple Sclerosis and Related Disorders.2022; 68: 104251.     CrossRef
  • Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
    Eli Hatchwell, Edward B. Smith, Shapour Jalilzadeh, Christopher D. Bruno, Yassine Taoufik, Houria Hendel-Chavez, Roland Liblau, David Brassat, Guillaume Martin-Blondel, Heinz Wiendl, Nicholas Schwab, Irene Cortese, Maria Chiara Monaco, Luisa Imberti, Rugg
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Complications neurologiques de l’infection par le virus JC : revue générale
    A. Moulignier, A. Lecler
    La Revue de Médecine Interne.2021; 42(3): 177.     CrossRef
  • The effect of tonsillectomy on John Cunningham virus serological status in multiple sclerosis patients: A retrospective case–control study
    Mirla Avila, Annette Okai, Smathorn Thakolwiboon, Collin O’Bryan, Murali Mohan Reddy Gopireddy, Sasikanth Gorantla
    Multiple Sclerosis Journal.2021; 27(8): 1297.     CrossRef
  • AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
    Siddharth Singh, Deborah Proctor, Frank I. Scott, Yngve Falck-Ytter, Joseph D. Feuerstein
    Gastroenterology.2021; 160(7): 2512.     CrossRef
  • Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis
    Shitiz Sriwastava, Saurabh Kataria, Samiksha Srivastava, Shaghayegh Kazemlou, Si Gao, Sijin Wen, Hamidreza Saber, Richa Tripathi, Zubeda Sheikh, Sarah Peterson, Ronald Gwinn, Evanthia Bernitsas
    Journal of Neuroimmunology.2021; 360: 577721.     CrossRef
  • Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
    Valery Danilenko, Andrey Devyatkin, Mariya Marsova, Madina Shibilova, Rustem Ilyasov, Vladimir Shmyrev
    Journal of Inflammation Research.2021; Volume 14: 6349.     CrossRef
  • Infections in patients diagnosed with multiple sclerosis: A multi-database study
    R. Persson, S. Lee, M. Ulcickas Yood, CAPT M. Wagner, USN, MC, N. Minton, S. Niemcryk, A. Lindholm, A.M. Evans, S.S. Jick
    Multiple Sclerosis and Related Disorders.2020; 41: 101982.     CrossRef
  • Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab
    Eleonora Sgarlata, Clara Grazia Chisari, Emanuele D’Amico, Enrico Millefiorini, Francesco Patti
    CNS Drugs.2020; 34(5): 535.     CrossRef
  • Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod
    Mitsuru Watanabe, Yuri Nakamura, Noriko Isobe, Masami Tanaka, Ayako Sakoda, Fumie Hayashi, Yuji Kawano, Ryo Yamasaki, Takuya Matsushita, Jun-ichi Kira
    Journal of Neuroinflammation.2020;[Epub]     CrossRef
  • John Cunningham Virus Status, Seroconversion Rate, and the Risk of Progressive Multifocal Leukoencephalopathy in Polish John Cunningham Virus-Seronegative Patients with Relapsing-Remitting Multiple Sclerosis
    Katarzyna Kapica-Topczewska, Francois Collin, Joanna Tarasiuk, Agata Czarnowska, Monika Chorąży, Anna Mirończuk, Jan Kochanowicz, Alina Kułakowska
    European Neurology.2020; 83(5): 487.     CrossRef
  • The spectrum of progressive multifocal leukoencephalopathy: a practical approach
    T. Bartsch, T. Rempe, F. Leypoldt, C. Riedel, O. Jansen, D. Berg, G. Deuschl
    European Journal of Neurology.2019; 26(4): 566.     CrossRef
  • Prevalence of Anti-JC Virus (JCV) Antibodies in the Multiple Sclerosis (MS) Population in Cyprus: A Retrospective Study
    Sakis Lambrianides, Christiana A. Demetriou, Andis Tillyris, Elena Kkolou, Eftychia Gaglia, Eleni Agkastinioti, Eleni Leonidou, Yiolanda-Panayiota Christou, Savvas S. Papacostas, Kleopas A. Kleopa, Theodoros Kyriakides, Marios Pantzaris
    Neurology Research International.2019; 2019: 1.     CrossRef
  • High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis
    Su-Hyun Kim, Yeseul Kim, Ji Yun Jung, Na-Young Park, Hyunmin Jang, Jae-Won Hyun, Ho Jin Kim
    Journal of Clinical Neurology.2019; 15(4): 454.     CrossRef
  • Three cases of non-carryover fingolimod-PML
    Jin Nakahara, Laura Tomaske, Kodai Kume, Tadayuki Takata, Masaki Kamada, Kazushi Deguchi, Kenji Kufukihara, Ruth Schneider, Ralf Gold, Ilya Ayzenberg
    Neurology - Neuroimmunology Neuroinflammation.2019; 6(3): e559.     CrossRef
  • Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration
    Shinji Aoyama, Masahiro Mori, Akiyuki Uzawa, Tomohiko Uchida, Hiroki Masuda, Ryohei Ohtani, Satoshi Kuwabara
    Journal of Neurology.2018; 265(5): 1145.     CrossRef
The impact of disease characteristics on multiple sclerosis patients’ quality of life
Aziz Rezapour, Abdollah Almasian Kia, Sahar Goodarzi, Mojtaba Hasoumi, Soraya Nouraei Motlagh, Sajad Vahedi
Epidemiol Health. 2017;39:e2017008.   Published online February 19, 2017
DOI: https://doi.org/10.4178/epih.e2017008
  • 13,067 View
  • 365 Download
  • 36 Citations
AbstractAbstract PDF
Abstract
OBJECTIVES
The aim of this study was to assess the quality of life (QoL) of patients with multiple sclerosis (MS), and to investigate the effects of characteristics of MS such as disease course, severity, and relapses on patients’ QoL.
METHODS
This was a cross-sectional study, in which 171 patients were enrolled. Health-related QoL was assessed using the Persian version of the Multiple Sclerosis Quality of Life-54 questionnaire. To measure patients’ disability status, we used the Expanded Disability Status Scale. Other variables included in the study were disease course and relapses of the disease.
RESULTS
The average scores for patients’ physical and mental QoL were 60.9±22.3 and 59.5±21.4, respectively. In a bivariate analysis, disease course, severity of the disease, and relapses were significantly associated with the physical and mental health composite scores. In a hierarchal regression analysis, disease course, severity of the disease, and relapses were responsible for 38 and 16% of the variance in physical and mental QoL, respectively. It was also observed that relapses were a strong predictor of both physical and mental QoL.
CONCLUSIONS
Our results showed that disease characteristics significantly affected both dimensions of QoL. It is therefore suggested that health care providers should be aware of these characteristics of MS to more successfully improve MS patients’ QoL.
Summary
Korean summary
Key Message

Citations

Citations to this article as recorded by  
  • Representing disabling experiences: Rethinking quality of life when evaluating public health interventions
    Karl Atkin, Maria Berghs, Sangeeta Chattoo
    Politics & Policy.2023; 51(1): 41.     CrossRef
  • Factors that influence quality of life in patients with multiple sclerosis in Saudi Arabia
    Fuad A. Abdulla, Faisal M. Albagmi, Fahd A. Al-Khamis
    Disability and Rehabilitation.2022; 44(17): 4775.     CrossRef
  • Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies
    Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni, Kottil Rammohan, Thomas Leist, Patricia K Coyle, Fernando Dangond, Birgit Keller, Nektaria Alexandri, Andrew Galazka
    Multiple Sclerosis Journal.2022; 28(1): 111.     CrossRef
  • Short quality of life scale: A cross-cultural validation in Iranian patients with multiple sclerosis
    Samira Zarrabi-Ajami, Hadi Zamanian, Mohammadali Amini-Tehrani, Zahra Farhadidanaloo, Razieh Janati Razavi, Azam Abbasi, Saeideh Darbandi, Pegah Chenari
    Multiple Sclerosis and Related Disorders.2022; 58: 103411.     CrossRef
  • Therapeutic Potential of Combined Therapy of Vitamin A and Vitamin C in the Experimental Autoimmune Encephalomyelitis (EAE) in Lewis Rats
    Mojdeh Navidhamidi, Atena Nazari, Samaneh Dehghan, Anahita Ebrahimpour, Reza Nasrnezhad, Fereshteh Pourabdolhossein
    Molecular Neurobiology.2022; 59(4): 2328.     CrossRef
  • Health-Related Quality of Life in people with Multiple Sclerosis: How does this Population Compare to Population-based Norms in Different Health Domains?
    Erin Faraclas, Jeff Lynn, Jeffery D. Lau, Angela Merlo
    Journal of Patient-Reported Outcomes.2022;[Epub]     CrossRef
  • Pelvic floor muscle training in multiple sclerosis patients with lower urinary tract dysfunction: A systematic review and meta-analysis
    Mehrnaz Kajbafvala, Zinat Ashnagar, Adelia Lucio, Fahimeh Firoozeh, Reza Salehi, Fariba Pashazadeh, Mehdi Dadgoo, Hassan Jafari
    Multiple Sclerosis and Related Disorders.2022; 59: 103559.     CrossRef
  • Improvement of gait and balance in patients with multiple sclerosis after multidisciplinary physical rehabilitation: Analysis of real-world data in Russia
    A. Stepanova, G Makshakov, A. Kulyakhtin, I. Kalinin, P Feys, E. Evdoshenko
    Multiple Sclerosis and Related Disorders.2022; 59: 103640.     CrossRef
  • The Relationship Between Adaptation to Disease and Self-care Agency Levels in Patients With Multiple Sclerosis
    Aysun Bayram, Afife Yurttaş
    Journal of Neuroscience Nursing.2022; 54(2): 102.     CrossRef
  • The validity, responsiveness, and score interpretation of the PROMISnq Physical Function – Multiple Sclerosis 15a short form in multiple sclerosis
    Paul Kamudoni, Dagmar Amtmann, Jeffrey Johns, Karon F. Cook, Rana Salem, Sam Salek, Jana Raab, Rod Middleton, Pavle Repovic, Kevin N. Alschuler, Gloria von Geldern, Annette Wundes, Amy Barrett, Oyebimpe Olayinka-Amao, Christian Henke
    Multiple Sclerosis and Related Disorders.2022; 62: 103753.     CrossRef
  • Fatigue, Depression, and Anxiety Among Ambulating Multiple Sclerosis Patients
    Safanah AlSaeed, Tamadher Aljouee, Nuha M. Alkhawajah, Rola Alarieh, Hanan AlGarni, Salman Aljarallah, Mohsen Ayyash, Amani Abu-Shaheen
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Age, motor dysfunction and neuropsychiatric symptoms impact quality of life in multiple sclerosis
    Patrícia de Morais Ferreira Brandão, Tayla Borges Lino, Renata Terra de Oliveira, Andrelisa Vendrami Parra, Paulo Henrique Muleta Andrade, Gustavo Christofoletti
    Revista Brasileira de Enfermagem.2022;[Epub]     CrossRef
  • Avoidant Coping Is Associated with Quality of Life in Persons with Multiple Sclerosis with High Cognitive Reserve
    Samantha M Vervoordt, Megan L Bradson, Peter A Arnett
    Archives of Clinical Neuropsychology.2022; 37(7): 1527.     CrossRef
  • Impact of autologous HSCT on the quality of life and fatigue in patients with relapsing multiple sclerosis
    N. Giedraitiene, G. Gasciauskaite, G. Kaubrys
    Scientific Reports.2022;[Epub]     CrossRef
  • Perceived facilitators, needs, and barriers to health related quality of life in people with multiple sclerosis: a qualitative investigation
    Erin Faraclas, Angela Merlo, Jeff Lynn, Jeffery D. Lau
    Journal of Patient-Reported Outcomes.2022;[Epub]     CrossRef
  • Neuroprotective Effects of Black Pepper and Its Bioactive Compounds in Age-Related Neurological Disorders
    Rengasamy Balakrishnan, Shofiul Azam, In-Su Kim, Dong-Kug Choi
    Aging and disease.2022;[Epub]     CrossRef
  • Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis
    Jennifer Fransson, Ana Isabel Gómez-Conde, Jesús Romero-Imbroda, Oscar Fernández, Laura Leyva, Fernando Rodríguez de Fonseca, Jerold Chun, Celine Louapre, Anne Baron Van-Evercooren, Violetta Zujovic, Guillermo Estivill-Torrús, Beatriz García-Díaz
    Molecular Neurobiology.2021; 58(2): 470.     CrossRef
  • Perceived social support, mental health, and marital satisfaction in multiple sclerosis patients
    Şükrü Özen, Tuğba Karataş, Ülkü Polat
    Perspectives in Psychiatric Care.2021; 57(4): 1862.     CrossRef
  • Virtual reality is a feasible intervention platform in multiple sclerosis: A pilot protocol and acute improvements in affect
    Michael T. Shaw, Maria J. Palmeri, Martin Malik, Bryan Dobbs, Leigh E. Charvet
    Multiple Sclerosis Journal - Experimental, Translational and Clinical.2021; 7(2): 205521732110061.     CrossRef
  • Sensorimotor function does not predict quality of life in persons with multiple sclerosis
    Philipp Gulde, Joachim Hermsdörfer, Peter Rieckmann
    Multiple Sclerosis and Related Disorders.2021; 52: 102986.     CrossRef
  • Fear of relapse in patients suffering from RRMS influence their quality of life
    Ali Khatibi, Tracey J Weiland, Mohsen Dehghani
    Multiple Sclerosis and Related Disorders.2021; 54: 103137.     CrossRef
  • Piperine Improves Experimental Autoimmune Encephalomyelitis (EAE) in Lewis Rats Through its Neuroprotective, Anti-inflammatory, and Antioxidant Effects
    Reza Nasrnezhad, Sohrab Halalkhor, Farzin Sadeghi, Fereshteh Pourabdolhossein
    Molecular Neurobiology.2021; 58(11): 5473.     CrossRef
  • Quality of Life of Children and Adolescents with Multiple Sclerosis—A Literature Review of the Quantitative Evidence
    Slávka Mrosková, Eleonóra Klímová, Ľudmila Majerníková, Ľubomíra Tkáčová
    International Journal of Environmental Research and Public Health.2021; 18(16): 8645.     CrossRef
  • A theory of mind training for people with multiple sclerosis: Development of a scale to assess the treatment acceptability
    Alessia d’Arma, Annalisa Valle, Sonia Di Tella, Davide Massaro, Marco Rovaris, Francesca Baglio, Antonella Marchetti
    Current Psychology.2021;[Epub]     CrossRef
  • Associations between Lifestyle Behaviors and Quality of Life Differ Based on Multiple Sclerosis Phenotype
    Nupur Nag, Maggie Yu, George Jelinek, Steve Simpson-Yap, Sandra Neate, Hollie Schmidt
    Journal of Personalized Medicine.2021; 11(11): 1218.     CrossRef
  • Coping Strategies and Their Impact on Quality of Life and Physical Disability of People with Multiple Sclerosis
    Silvia Cerea, Marta Ghisi, Marco Pitteri, Maddalena Guandalini, Lauren B. Strober, Simona Scozzari, Francesco Crescenzo, Massimiliano Calabrese
    Journal of Clinical Medicine.2021; 10(23): 5607.     CrossRef
  • The Relationship Between Aspects of Resiliency and Intimacy-Related Illness Intrusiveness in Males with Multiple Sclerosis
    Lindsay Neto, Elizabeth S. Gromisch, Jessica Sloan, Tuula Tyry, Frederick W. Foley
    Sexuality and Disability.2020; 38(1): 135.     CrossRef
  • Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study


    Dirk Schriefer, Rocco Haase, Jennifer S Kullmann, Tjalf Ziemssen
    Patient Preference and Adherence.2020; Volume 14: 869.     CrossRef
  • Quality of life among patients with multiple sclerosis and voiding dysfunction: a cross-sectional study
    Fatemeh Nazari, Vahid Shaygannejad, Mehrdad Mohammadi Sichani, Marjan Mansourian, Valiollah Hajhashemi
    BMC Urology.2020;[Epub]     CrossRef
  • Mindfulness-Based Interventions for the Improvement of Well-Being in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Sara Carletto, Cesare Cavalera, Isabel Sadowski, Marco Rovaris, Martina Borghi, Bassam Khoury, Luca Ostacoli, Francesco Pagnini
    Psychosomatic Medicine.2020; 82(6): 600.     CrossRef
  • Der Einfluss von MS-spezifischen Symptomen auf die gesundheitsbezogene Lebensqualität
    Lydia Sander, Joachim Kugler, Bernhard Elsner
    Fortschritte der Neurologie · Psychiatrie.2020; 88(11): 704.     CrossRef
  • Quality of life in adults with multiple sclerosis: a systematic review
    Irene Gil-González, Agustín Martín-Rodríguez, Rupert Conrad, María Ángeles Pérez-San-Gregorio
    BMJ Open.2020; 10(11): e041249.     CrossRef
  • Comparison of Lower Urinary System Symptoms of Women with Multiple Sclerosis and Healthy
    Gözde TEKİN, Nuriye ÖZENGİN, Sule AYDIN TÜRKOĞLU, Handan ANKARALI, Yeşim BAKAR
    Anadolu Kliniği Tıp Bilimleri Dergisi.2020;[Epub]     CrossRef
  • Sex differences in predictors of illness intrusiveness in persons with multiple sclerosis
    Lindsay O. Neto, Elizabeth S. Gromisch, Jessica Sloan, Tuula Tyry, Frederick W. Foley
    Quality of Life Research.2019; 28(2): 389.     CrossRef
  • Validation of the Indonesian version of multiple sclerosis quality of life-54 (MSQOL-54 INA) questionnaire
    Riwanti Estiasari, Syarly Melani, A. A. A. Agung Kusumawardhani, David Pangeran, Yuhyi Fajrina, Kartika Maharani, Darma Imran
    Health and Quality of Life Outcomes.2019;[Epub]     CrossRef
  • A Controlled Clinical Trial on the Effects of Exercise on Lower Urinary Tract Symptoms in Women With Multiple Sclerosis
    Ana Paula Silva Ferreira, Ana Beatriz Gomes de Souza Pegorare, Ari Miotto Junior, Pedro Rippel Salgado, Fausto Orsi Medola, Gustavo Christofoletti
    American Journal of Physical Medicine & Rehabilitation.2019; 98(9): 777.     CrossRef
Burden of Disease of Multiple Sclerosis in Korea
Soo-Eun Chung, Hae-Kwan Cheong, Jae-Hyun Park, Ho Jin Kim
Epidemiol Health. 2012;34:e2012008.   Published online November 30, 2012
DOI: https://doi.org/10.4178/epih/e2012008
  • 16,984 View
  • 143 Download
  • 19 Citations
AbstractAbstract PDF
Abstract
OBJECTIVES

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. There are few reports on the burden of disease of MS, worldwide. The authors aim to estimate burden of disease and estimate the epidemiologic indexes of MS in Korea using available epidemiologic data.

METHODS

Epidemiologic indexes were computed using DISMOD II software based on prevalence from nationwide survey, incidence estimated from extrapolation, mortality from National Statistics Office, and duration of disease from literature as input indexes. We calculated disability-adjusted life year (DALY) as a measure of premature mortality and disability, equivalent to years of healthy life lost due to a given condition.

RESULTS

The incidence of MS in Korea was 0.1 per 100,000, higher in female than in male. The highest incidence was estimated in the age group between 35 and 44 years in male and age group between 25 and 29 years in female. Total burden of disease of MS was 1,394 DALY, comprised of 292 (21%) years of life lost and 1,101 (79%) years lived with disability. The mean age at onset of MS was 33 years old in men and 32 years old in female. Estimated duration of disease was 35 years in men and 40 years in female. Most of the DALY of MS occurred in the adult population between 25 and 54 years of age.

CONCLUSION

Although MS is a rare disease in Korea, most of the DALY arises from young people, which results in a major financial burden on the patient, family, health system and society.

Summary
Korean summary
Key Message

Citations

Citations to this article as recorded by  
  • Incidencia y prevalencia de la esclerosis múltiple en China y países asiáticos
    G.X. Zhang, A. Carrillo-Vico, W.T. Zhang, S.S. Gao, G. Izquierdo Ayuso
    Neurología.2023; 38(3): 159.     CrossRef
  • Incidence and prevalence of multiple sclerosis in China and other Asian countries
    G.X. Zhang, A. Carrillo-Vico, W.T. Zhang, S.S. Gao, G. Izquierdo Ayuso
    Neurología (English Edition).2023; 38(3): 159.     CrossRef
  • Hypophosphatemic Rickets in Colombia: A Prevalence-Estimation Model in Rare Diseases. 2018
    Jancy Andrea Huertas-Quintero, Natalia Losada-Trujillo, Diego Alberto Cuellar-Ortiz, Harvy Mauricio Velasco-Parra
    The Lancet Regional Health - Americas.2022; 7: 100131.     CrossRef
  • A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China
    Tan Guojun, Xu Yan, Wang Weizhi, Wang Lihua, Li Chunyang, Zhang Xinghu, Zhou Hongyu, Dong Huiqing, Zhang Meini, Jin Tao, Yang Huan, Cui Liying, Guo Li
    Multiple Sclerosis and Related Disorders.2022; 60: 103732.     CrossRef
  • The analysis of dynamic gene expression patterns in peripheral blood of multiple sclerosis patients indicates possible diagnostic and prognostic biomarkers
    Rabat Razia, Fazeel Majeed, Rehab Amin, Shahid Mukhtar, Khalid Mehmood, Deeba Noreen Baig
    Molecular Immunology.2022; 147: 147.     CrossRef
  • Identification of blood-derived candidate gene markers and a new 7-gene diagnostic model for multiple sclerosis
    Xin Chen, Huiqing Hou, Huimin Qiao, Haolong Fan, Tianyi Zhao, Mei Dong
    Biological Research.2021;[Epub]     CrossRef
  • Epidemiology, treatment patterns and healthcare utilizations in multiple sclerosis in Taiwan
    Chia-Yun Hsu, Long-Sun Ro, Li-Ju Chen, Chun-Wei Chang, Kuo-Hsuan Chang, I-Hsuan Wu, Amy Lin, Fei-Yuan Hsiao
    Scientific Reports.2021;[Epub]     CrossRef
  • Burden of multiple sclerosis in Iran from 1990 to 2017
    Nima Fattahi, Sahar Saeedi Moghaddam, Farnam Mohebi, Negar Rezaei, Masoud Masinaei, Sahar Mohammadi Fateh, Elham Soleymani Hassanlouei, Farhad Manoochehri, Eghbal Fattahi, Mohammad Ali Sahraian, Maziar Moradi-lakeh, Ali H. Mokdad, Mohsen Naghavi, Farshad
    BMC Neurology.2021;[Epub]     CrossRef
  • Optic neuritis in German children: clinical findings and association with multiple sclerosis
    Felix Tonagel, Helmut Wilhelm, Carina Kelbsch
    Graefe's Archive for Clinical and Experimental Ophthalmology.2020; 258(7): 1523.     CrossRef
  • Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999–2018
    Amir Almasi-Hashiani, Mohammad Ali Sahraian, Sharareh Eskandarieh
    BMC Neurology.2020;[Epub]     CrossRef
  • Epstein-Barr virus infection as a predisposing factor for multiple sclerosis. An update from molecular biology, immunology and epidemiology
    David López-Valencia, Ángela Medina-Ortega, Diego Fernando Hoyos-Samboní, Jhan Sebastián Saavedra-Torres, Carolina Salguero
    Revista de la Facultad de Medicina.2019; 67(3): 305.     CrossRef
  • Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
    Elmira Agah, Arshia Zardoui, Amene Saghazadeh, Mona Ahmadi, Abbas Tafakhori, Nima Rezaei, Heinz Wiendl
    PLOS ONE.2018; 13(1): e0190252.     CrossRef
  • Using inpatient data to estimate the prevalence of Wegener's granulomatosis in China
    Xiao Liu, Yazhou Cui, Yan Li, Chao Wang, Heng Zhao, Jinxiang Han
    Intractable & Rare Diseases Research.2016; 5(1): 31.     CrossRef
  • Estimating epidemiological data of Multiple sclerosis using hospitalized data in Shandong Province, China
    Xiao Liu, Yazhou Cui, Jinxiang Han
    Orphanet Journal of Rare Diseases.2016;[Epub]     CrossRef
  • Epidemiology of Multiple Sclerosis
    Jonathan Howard, Stephen Trevick, David S. Younger
    Neurologic Clinics.2016; 34(4): 919.     CrossRef
  • Quantifying Burden of Disease to Measure Population Health in Korea
    Jihyun Yoon, Seok-Jun Yoon
    Journal of Korean Medical Science.2016; 31(Suppl 2): S101.     CrossRef
  • Modeling the Burden of Abdominal Aortic Aneurysm in the USA in 2013
    Mark Stuntz
    Cardiology.2016; 135(2): 127.     CrossRef
  • Optic Neuritis in Korean Children: Low Risk of Subsequent Multiple Sclerosis
    Young Mi Kim, Hye Young Kim, Min Jeong Cho, Min Jung Kwak, Kyung Hee Park, Gyu Min Yeon, Yunjin Lee, Sang Ook Nam
    Pediatric Neurology.2015; 53(3): 221.     CrossRef
  • No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population
    S. Namgoong, J. S. Bae, H. S. Cheong, J.-H. Kim, J. Y. Kim, L. H. Kim, H. J. Kim, H. D. Shin
    Tissue Antigens.2014; 84(2): 223.     CrossRef

Epidemiol Health : Epidemiology and Health